Abacus Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
11,511
-4,318
-27% -$505K 0.16% 47
2026
Q1
$1.9M Buy
15,829
+792
+5% +$91.4K 0.17% 44
2025
Q4
$1.58M Buy
15,037
+5,913
+65% +$555K 0.16% 56
2025
Q3
$766K Buy
9,124
+43
+0.5% +$3.54K 0.11% 40
2025
Q2
$719K Sell
9,081
-144
-2% -$11.4K 0.11% 40
2025
Q1
$828K Sell
9,225
-898
-9% -$83.8K 0.12% 31
2024
Q4
$1.01M Sell
10,123
-449
-4% -$46.3K 0.15% 29
2024
Q3
$1.2M Sell
10,572
-852
-7% -$101K 0.18% 26
2024
Q2
$1.41M Buy
11,424
+279
+3% +$35.9K 0.23% 24
2024
Q1
$1.47M Buy
11,145
+1,263
+13% +$156K 0.25% 24
2023
Q4
$1.08M Buy
9,882
+719
+8% +$74.6K 0.18% 27
2023
Q3
$943K Buy
9,163
+1,826
+25% +$197K 0.29% 26
2023
Q2
$847K Sell
7,337
-312
-4% -$35.4K 0.26% 25
2023
Q1
$900K Buy
7,649
+351
+5% +$37.9K 0.3% 26
2022
Q4
$810K Hold
7,298
0.29% 24
2022
Q3
$629K Hold
7,298
0.33% 29
2022
Q2
$665K Sell
7,298
-264
-3% -$23.4K 0.35% 28
2022
Q1
$620K Sell
7,562
-74
-1% -$5.83K 0.28% 34
2021
Q4
$585K Sell
7,636
-445
-6% -$35.4K 0.21% 46
2021
Q3
$607K Sell
8,081
-17
-0.2% -$1.29K 0.22% 41
2021
Q2
$630K Sell
8,098
-1,026
-11% -$76.3K 0.25% 33
2021
Q1
$671K Buy
9,124
+1,839
+25% +$136K 0.48% 29
2020
Q4
$569K Buy
+7,285
New +$557K 0.5% 30

Other funds holding MRK

Abacus Wealth Partners's MRK Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Merck (MRK) stake by 27% in Q2 2026, selling an estimated $505K and leaving 11,511 shares worth $1.48M. The position accounts for 0.16% of the portfolio, ranked #47.

Abacus Wealth Partners first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.9M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Abacus Wealth Partners held 11,511 shares of Merck worth $1.48M as of Q2 2026.
  • Abacus Wealth Partners sold 4,318 Merck shares in Q2 2026, an estimated $505K.
  • Merck made up 0.16% of Abacus Wealth Partners's portfolio in Q2 2026, its #47 holding.
  • Abacus Wealth Partners first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Abacus Wealth Partners's Merck position peaked at $1.9M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.